上海大学学报(自然科学版) ›› 2022, Vol. 28 ›› Issue (5): 821-830.doi: 10.12066/j.issn.1007-2861.2441

• • 上一篇    下一篇

piRNA 调节心血管疾病的分子机制进展

谢金鑫1, 杨子江1, 王红云1, 肖俊杰1,2()   

  1. 1.上海大学 生命科学学院 心血管研究所, 上海 200444
    2.上海大学 医学院 上海器官修复工程技术研究中心, 上海 200444
  • 收稿日期:2022-08-08 出版日期:2022-10-30 发布日期:2022-11-12
  • 通讯作者: 肖俊杰 E-mail:junjiexiao@shu.edu.cn
  • 作者简介:肖俊杰(1983—), 男, 教授, 博士生导师, 博士, 研究方向为运动诱导的生理性心肌肥大. E-mail: junjiexiao@shu.edu.cn
  • 基金资助:
    国家重点研发计划-政府间国际科技创新合作重点专项资助项目(2018YFE0113500);国家自然科学基金-重点国际(地区)合作研究资助项目(82020108002);国家自然科学基金资助项目(81911540486);国家自然科学基金资助项目(82000253)

Advances in the mechanism of piRNA regulating cardiovascular disease

XIE Jinxin1, YANG Zijiang1, WANG Hongyun1, XIAO Junjie1,2()   

  1. 1. Institute of Cardiovascular Sciences, School of Life Sciences, Shanghai University, Shanghai 200444, China
    2. Shanghai Engineering Research Center of Organ Repair, School of Medicine, Shanghai University, Shanghai 200444, China
  • Received:2022-08-08 Online:2022-10-30 Published:2022-11-12
  • Contact: XIAO Junjie E-mail:junjiexiao@shu.edu.cn

摘要:

PIWI-interacting RNA(piRNA)是一类最初从生殖细胞中发现的长约 30 nt 的新型内源性非编码 RNA, 能够与 PIWI 蛋白家族成员结合抑制转座子, 保持种系基因组完整性. 随着研究的不断深入, piRNA 被证实在生殖细胞以外的其他组织细胞中亦可表达, 并且在众多的生理病理过程中发挥着重要的调节作用. 心血管疾病(cardiovascular disease, CVD)是引发全球人口死亡的首要原因. 基于 piRNA 的生物发生过程深入讨论了其在不同心血管疾病中的作用及潜在机制, 归纳了可用于防治及诊断心血管疾病的 piRNA 发明专利, 以期丰富 piRNA 的分子生物学理论, 并为防治心血管疾病提供新靶点和潜在策略.

关键词: 心血管疾病, piRNA, 诊断, 药物开发专利

Abstract:

PIWI-interacting RNA (piRNA), a new type of endogenous non-coding RNA, was identified from germ cells. Approximately 30 nt long, piRNA plays an important role in regulating physical or pathological processes, including maintaining genomic integrity, via interacting with the PIWI protein family. Research advancements confirms that piRNA is widely expressed in several other tissues and cells. Cardiovascular disease (CVD) is a leading cause of mortality worldwide. The present review summarizes the role and underlying mechanism of piRNA in CVD models upon their biogenesis process and tissue distribution. It also examines CVD diagnosis- and treatment-associated patents. These rrsults may help enrich the molecular biological theory of piRNA and provide potential targets and strategies for the treatment of CVD.

Key words: cardiovascular disease(CVD), piRNA, diagnosis, drug development patents

中图分类号: